Glycolytic pathway affects differentiation of human monocytes to regulatory macrophages

Immunology Letters

Volumn 176, Issue , 2016, Pages 18-27

  Suzuki, Hiroaki ^a,b   Hisamatsu, Tadakazu ^a,c   Chiba, Sayako ^a   Mori, Kiyoto ^a   Kitazume, Mina T ^a   Shimamura, Katsuyoshi ^a   Nakamoto, Nobuhiro ^a   Matsuoka, Katsuyoshi ^a   Ebinuma, Hirotoshi ^a   Naganuma, Makoto ^a   Kanai, Takanori ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Research Center   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation; Glycolytic pathway; Human monocyte; Regulatory macrophage

Indexed keywords

COLONY STIMULATING FACTOR 1; DEOXYGLUCOSE; DICHLOROACETIC ACID; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PYRUVIC ACID; VASCULOTROPIN A; 2-DEOXY-GLUCOSE TETRAACETATE; COLONY STIMULATING FACTOR; CYTOKINE; GLUCOSE; MMP9 PROTEIN, HUMAN; TRANSCRIPTOME; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL PLASTICITY; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MACROPHAGE; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM;

CELL DIFFERENTIATION; CELLS, CULTURED; COLONY-STIMULATING FACTORS; CYTOKINES; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOLYSIS; HUMANS; IMMUNOMODULATION; INTERLEUKIN-10; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MONOCYTES; PYRUVIC ACID; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84971281324     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2016.05.009     Document Type: Article

References (50)

1. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737. 10.1038/nri3073.
2. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964. 10.1038/nri1733.
3. Antonio S., Albelto M. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795. 10.1172/JCI59643DS1.
4. Kamada N., Hisamatsu T., Okamoto S., Sato T., Matsuoka K., Arai K., et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J. Immunol. 2005, 175:6900-6908. 175/10/6900 [ii].
5. Verreck F.A.W., De Boer T., Langenberg D.M.L., Van Der Zanden L., Ottenhoff T.H.M. Phenotypic and functional pro ling of human proin ammatory type-1 and anti-in ammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J. Leukoc. Biol. 2006, 79:285-293. 10.1189/jlb.0105015.Journal.
6. Takada Y., Hisamatsu T., Kamada N., Kitazume M.T., Honda H., Oshima Y., et al. Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset. J. Immunol. 2010, 184:2671-2676. 10.4049/jimmunol.0804012.
7. Mochida-Nishimura K., Akagawa K.S., a Rich E. Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte-macrophage colony-stimulating factor. Cell. Immunol. 2001, 214:81-88. 10.1006/cimm.2001.1801.
8. Hashimoto S., Yamada M., Motoyoshi K., Akagawa K.S. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 1997, 89:315-321.
9. Anthony R.M., Rutitzky L.I., Urban J.F., Stadecker M.J., Gause W.C. Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 2007, 7:975-987. 10.1038/nri2199.
10. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184. 10.1172/JCI29881.
11. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120. 10.1038/nature05894.
12. Ganeshan K., Chawla A. Metabolic regulation of immune responses. Annu. Rev. Immunol. 2014, 32:609-634. 10.1146/annurev-immunol-032713-120236.
13. Pearce E.L., Pearce E.J. Metabolic Pathways in immune cell activation and Quiescence. Immunity 2013, 38:633-643. 10.1016/j.biotechadv.2011.08.021.Secreted.
14. Phillip W., Igor B., Gerald S., Sankar G. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480. 10.1038/nature09973.
15. Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1&alpha. Nature 2013, 496:238-242. 10.1038/nature11986.
16. Hoque R., Farooq A., Ghani A., Gorelick F., Mehal W.Z. Lactate reduces liver and pancreatic injury in toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology 2014, 146:1763-1774. 10.1053/j.gastro.2014.03.014.
17. Haschemi A., Kosma P., Gille L., Evans C.R., Burant C.F., Starkl P., et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 2012, 15:813-826. 10.1016/j.cmet.2012.04.023.
18. Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006, 4:13-24. 10.1016/j.cmet.2006.05.011.
19. Huang S.C.-C., Everts B., Ivanova Y., O'sullivan D., Nascimento M., Smith A.M., et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 2014, 15:846-855. 10.1038/ni.2956.
20. Kamada N., Hisamatsu T., Okamoto S., Chinen H., Kobayashi T., Sato T., et al. Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis. J. Clin. Invest. 2008, 118:2269-2280. 10.1172/JCI34610.
21. Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014, 6:6-13. 10.12703/P.
22. Pelicano H., Martin D.S., Xu R.-H., Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646. 10.1038/sj.onc.1209597.
23. Michelakis E.D., Webster L., Mackey J.R. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br. J. Cancer. 2008, 99:989-994. 10.1038/sj.bjc.6604554.
24. Chang J., Hisamatsu T., Shimamura K., Yoneno K., Adachi M., Naruse H., et al. Activated hepatic stellate cells mediate the differentiation of macrophages. Hepatol. Res. 2013, 43:658-669. 10.1111/j.1872-034X.2012.01111.x.
25. M.G. Vander Heiden, Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 2011, 10:671-684. 10.1038/nrd3504.
26. Bonnet S., Archer S.L., Allalunis-Turner J., Haromy A., Beaulieu C., Thompson R., et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007, 11:37-51. 10.1016/j.ccr.2006.10.020.
27. Pixley F.J., Stanley E.R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 2004, 14:628-638. 10.1016/j.tcb.2004.09.016.
28. Rao Q., Zheng G.-G., Li G., Lin Y.-M., Wu K.-F. Membrane-bound macrophage colony-stimulating factor mediated auto-juxtacrine downregulates matrix metalloproteinase-9 release on J6-1 leukemic cell. Exp. Biol. Med. 2004, 229:946-953.
29. Ryan G.R., Dai X., Dominguez M.G., Tong W., Chuan F., Chisholm O., et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1 op/Csf1 op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001, 98:74-84. 10.1182/blood.V98.1.74.
30. Chitu V., Stanley E.R. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 2006, 18:39-48. 10.1016/j.coi.2005.11.006.
31. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544. 10.1038/nri2356.
32. Zheng G., Rao Q., Wu K., He Z., Geng Y. Membrane-bound macrophage colony-stimulating factor and its receptor play adhesion molecule-like roles in leukemic cells. Leuk. Res. 2000, 24:375-383. 10.1016/S0145-2126(99)00192-7.
33. Dai X., Zong X., Sylvestre V., Stanley E.R. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/CSF1op mice by transgenic expression of cell surface CSF-1. Blood 2004, 103:1114-1123. 10.1182/blood-2003-08-2739.Supported.
34. Zajac E., Schweighofer B., Kupriyanova T.A., Juncker-Jensen A., Minder P., Quigley J.P., et al. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood 2013, 122:4054-4067. 10.1182/blood-2013-05-501494.
35. Boorsma C.E., Draijer C., Melgert B.N. Macrophage heterogeneity in respiratory diseases. Mediators Inflamm. 2013, 2013:1-19. 10.1155/2013/769214.
36. Kiriakidis S., Andreakos E., Monaco C., Foxwell B., Feldmann M., Paleolog E. VEGF expression in human macrophages is NF-κB-dependent: studies using adenoviruses expressing the endogenous NF-κB inhibitor IκBα and a kinase-defective form of the IκB kinase 2. J. Cell Sci. 2003, 116:665-674. 10.1242/jcs.00286.
37. Das A., Sinha M., Datta S., Abas M., Chaffee S., Sen C.K., et al. Monocyte and macrophage plasticity in tissue repair and regeneration. Am. J. Pathol. 2015, 185:1-11. 10.1016/j.ajpath.2015.06.001.
38. Porcheray F., Viaud S., Rimaniol a.C., Léone C., Samah B., Dereuddre-Bosquet N., et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 2005, 142:481-489. 10.1111/j.1365-2249.2005.02934.x.
39. Das A., Ganesh K., Khanna S., Sen C.K., Roy S. Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J. Immunol. 2014, 192:1120-1129. 10.4049/jimmunol.1300613.
40. Chen M., Krishnamurthy a, Mohamed a R., Green R. Hematological disorders following gastric bypass surgery: emerging concepts of the interplay between nutritional deficiency and inflammation. Biomed. Res. Int. 2013, 2013:205467. 10.1155/2013/205467.
41. K.D. Jones, J.A. Berkley, Childhood malnutrition: toward an understanding of infections, inflammation, and antimicrobials, 35, (2014).
42. Justus C., Sanderlin E., Yang L. Molecular connections between cancer cell metabolism and the tumor microenvironment. Int. J. Mol. Sci. 2015, 16:11055-11086. 10.3390/ijms160511055.
43. Das U.N. Is pyruvate an endogenous anti-inflammatory molecule?. Nutrition 2006, 22:965-972. 10.1016/j.nut.2006.05.009.
44. Miljkovic D., Blaevski J., Petkovic F., Djedovic N., Momcilovic M., Stanisavljevic S., et al. A comparative analysis of multiple sclerosis-relevant anti-inflammatory properties of ethyl pyruvate and dimethyl fumarate. J. Immunol. 2015, 194:2493-2503. 10.4049/jimmunol.1402302.
45. Zeng J., Liu J., Yang G.-Y., Kelly M.J.S., James T.L., Litt L. Exogenous ethyl pyruvate versus pyruvate during metabolic recovery after oxidative stress in neonatal rat cerebrocortical slices. Anesthesiology 2007, 107:630-640. 10.1097/01.anes.0000281898.01966.1e.
46. Song M., Kellum J.A., Kaldas H., Fink M.P. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J. Pharmacol. Exp. Ther. 2004, 308:307-316. 10.1124/jpet.103.056622.
47. Tan Z., Xie N., Cui H., Moellering D.R., Abraham E., Thannickal V.J., et al. Pyruvate dehydrogenate kinase 1 participates in macrophage polarization via regulating glucose metabolism. J. Immunol. 2015, 10.4049/jimmunol.1402469.
48. Jones N.P., Schulze A. Targeting cancer metabolism-aiming at a tumour's sweet-spot. Drug Discov. Today 2012, 17:232-241. 10.1016/j.drudis.2011.12.017.
49. Noy R., Pollard J.W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014, 41:49-61. 10.1016/j.immuni.2014.06.010.
50. Tang X., Mo C., Wang Y., Wei D., Xiao H. Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology 2013, 138:93-104. 10.1111/imm.12023.